UNSPSC 51384505: Cinaproxen

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1J0E0I69E9. European Medicines Agency schedules Cinaproxen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06286MIG. Cinaproxen generally arises in the molecular formula C19H21NO5S.

UNSPSC 51384505 Cinaproxen is a Commodity code that reflects pharmaceutical products state and local governments procure for public health and emergency response initiatives, though recent solicitations show limited direct procurement of cinaproxen itself. Instead, state and local health agencies and county governments are actively sourcing naloxone and drug deactivation systems — opioid-response medications and harm-reduction equipment — through competitive bidding processes. The code appears to encompass a broader pharmaceutical and medical-supply family that includes both prescription medications and emergency medical products used in community health programs, substance-abuse mitigation, and public safety operations.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The procurement requires unit pricing from vendors, E-Verify compliance, drug-free workplace certification, and standard commercial insurance coverage. The contract structure includes an initial two-year term with a one-year renewal option and is potentially funded through FEMA, triggering adherence to federal environmental regulations. Geographic activity under this code is concentrated in Florida based on the recent record; the single posted opportunity limits visibility into broader state and local activity patterns across other jurisdictions.